Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Bellicum Pharmaceuticals

    Client Virtual Booth

    BELLICUM PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Bellicum Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Life Science Plaza 2130 West Holcombe Boulevard, Suite 800 Houston, Texas 77030
    Telephone
    Telephone
    (832) 384-1100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bellicum.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bellicum
    Twitter
    Twitter
    https://twitter.com/BellicumPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Bellicum halts trials after serious adverse event, looks for 'alternatives'
    Bellicum halts trials after serious adverse event, looks for 'alternatives'

    https://endpts.com/bellicum-halts-trials-after-serious-adverse-event-looks-for-strategic-alternatives/

    Katherine Lewin ENDPTS
    16 Mar 2023
    Share Share
    Bellicum Presents Early PI Results for BPX-601 in Prostate Cancer at ASCO GU
    Bellicum Presents Early PI Results for BPX-601 in Prostate Cancer at ASCO GU

    https://www.globenewswire.com/news-release/2023/02/16/2609615/0/en/Bellicum-Presents-Early-Phase-1-Results-for-BPX-601-in-Prostate-Cancer-at-ASCO-GU-Cancers-Symposium.html

    GLOBENEWSWIRE
    16 Feb 2023
    Share Share
    Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2023/01/31/2599032/0/en/CORRECTION-Bellicum-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    31 Jan 2023
    Share Share
    Bellicum to Present Phase 1 Results for BPX-601 in Prostate Cancer at ASCO
    Bellicum to Present Phase 1 Results for BPX-601 in Prostate Cancer at ASCO

    https://www.globenewswire.com/news-release/2023/01/19/2591682/0/en/Bellicum-Pharmaceuticals-to-Present-Early-Phase-1-Results-for-BPX-601-in-Prostate-Cancer-at-ASCO-2023-Genitourinary-Cancers-Symposium.html

    GLOBENEWSWIRE
    19 Jan 2023
    Share Share
    Bellicum Announces Presentatioat on Abrogation of iC9 CAR T-Cell Toxicities
    Bellicum Announces Presentatioat on Abrogation of iC9 CAR T-Cell Toxicities

    https://www.globenewswire.com/news-release/2022/12/11/2571433/0/en/Bellicum-Announces-Presentation-by-UNC-at-ASH-2022-on-Potential-Abrogation-of-iC9-CAR-T-Cell-Toxicities-with-Rimiducid.html

    GLOBENEWSWIRE
    11 Dec 2022
    Share Share
    Bellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting
    Bellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting

    https://www.globenewswire.com/news-release/2022/10/04/2527684/0/en/Bellicum-Pharmaceuticals-to-Participate-in-the-2022-Cell-Gene-Meeting-on-the-Mesa.html

    GLOBENEWSWIRE
    04 Oct 2022
    Share Share
    Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2022/10/03/2527307/0/en/Bellicum-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    03 Oct 2022
    Share Share
    Bellicum to Participate in the H.C. Wainwright 24th Annual Global
    Bellicum to Participate in the H.C. Wainwright 24th Annual Global

    https://www.globenewswire.com/news-release/2022/09/01/2508425/0/en/Bellicum-Pharmaceuticals-to-Participate-in-the-H-C-Wainwright-24th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    01 Sep 2022
    Share Share
    Bellicum Reports Q2 2022 Rusult and Provides Operational Update
    Bellicum Reports Q2 2022 Rusult and Provides Operational Update

    https://www.globenewswire.com/news-release/2022/08/11/2497095/0/en/Bellicum-Reports-Second-Quarter-2022-Financial-Results-and-Provides-Operational-Update.html

    GLOBENEWSWIRE
    11 Aug 2022
    Share Share
    Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2022/07/01/2472842/0/en/Bellicum-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Jul 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search